Evolution of Treatment Modalities for Posttraumatic Stress Disorder: Top 100 Cited Articles From 1990 to 2020.

Posttraumatic stress disorder (PTSD) is seen in a substantial proportion of individuals experiencing trauma. The last few decades have been significant in terms of PTSD-related research; however, a quantitative charting of the evolution in evidence-based treatment modalities for PTSD is lacking. The objective of this study was to conduct a bibliometric analysis to bridge this gap in knowledge.

On the generalization of Hermite-Hadamard type inequalities for -convex function via fractional integrals.

The main motivation in this article is to prove new integral identities and related results. In this paper, we deal with -convex function, Hermite-Hadamard type inequalities, and Katugampola fractional integrals. Firstly, we established the Hermite-Hadamard type inequalities for -convex function via Katugampola fractional integrals operators.

Systematic Analysis of the Effect of Benzene on the Corrosion Inhibition Performance of Imidazoline Derivatives: Experimental and Theoretical Research.

Imidazoline derivatives are widely used to prevent corrosion due to their toxicity and mitigation potential. The present study deals with the synthesis of two imidazole Schiff derivatives (JSMP and JSPP) based on imidazole hexanoate (JSMZ). The corrosion mitigation potential and mechanism in 1.

Efficacy and safety of the FGF19 analog aldafermin for the treatment of nonalcoholic steatohepatitis: a GRADE assessed systematic review and meta-analysis.

Background: Nonalcoholic fatty liver disease (NAFLD) is increasingly concerning due to its rising prevalence. It encompasses conditions from simple steatosis to severe nonalcoholic steatohepatitis (NASH), posing risks such as fibrosis, cirrhosis, or hepatocellular carcinoma if untreated. This systematic review and meta-analysis aims to assess aldafermin, an FGF19 analog, for efficacy and safety in NASH patients.

Efficacy and safety of resmetirom for the treatment of nonalcoholic steatohepatitis: a GRADE assessed systematic review and meta-analysis.

There are no Food and Drug Administration (FDA)-approved treatment options for nonalcoholic steatohepatitis (NASH) which is a prevailing disease that leads to fibrosis, cirrhosis, or hepatocellular carcinoma. Hence, this systematic review and meta-analysis aims to determine the efficacy and safety of resmetirom, the first FDA-approved drug, for the treatment of NASH. A Grading of Recommendations, Assessment, Development, and Evaluation assessed systematic search of Cochrane Library, MEDLINE, Scopus, and Google Scholar database was conducted from inception till 31 March 2024.